Skip to content Skip to footer

News and Insights

Insights

GLP-1 medications reduce weight and lower cardiovascular risk: a major advance with caveats

→ Many people stop taking them, and weight, and so presumably risk, return. Are we fixing the causes of disease? → No, we are badly managing the consequences of the same environments that created it. Medication can reduce risk. It cannot replace nutrition, movement, education, or healthy food systems. Obesity, longevity, and what “health” really

Insights

The Current State of Resuming Clinical Trials in Ukraine

Despite the challenges posed by the ongoing conflict, Ukraine’s healthcare sector demonstrates remarkable resilience and adaptability. The country’s efforts to maintain and enhance its healthcare and research infrastructure are also keeping clinical trials on schedule. As we discussed in this article on Linkedin, over the past few decades, Ukraine has established itself as a strong option

Leave a request or contact us in any convenient way for you.